Radiopharmaceutical Chemistry and Applications
Radiopharmaceutical Chemistry and Applications is a research topic within Radiology, Nuclear Medicine and Imaging. Science Explorer counts 44k research works in it since 1950. 15.2% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on the development, synthesis, and application of radiopharmaceuticals for PET and SPECT imaging, targeted therapy, radioimmunotherapy, and alpha particle therapy in cancer treatment. It covers topics such as coordinating radiometals, chelators, dosimetry, and the use of specific radionuclides for therapeutic purposes.
- Radiopharmaceuticals
- PET Imaging
- Targeted Therapy
- Radioimmunotherapy
- Alpha Particle Therapy
- Chelators
- Nuclear Medicine
- Bifunctional Agents
- Dosimetry
- Cancer Treatment
- Research works
- 44k fractional, since 1950
- In the world top 10%
- 6.6k per year above
- Top-10% rate
- 15.2% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- +11% the tick is no change
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Radiopharmaceutical Chemistry and Applications research?
By volume, the United States and China publish the most (1.5k and 810 works in 2022–2025).
By volume, 2022–2025
- 1 United States 1.5k works
- 2 China 810 works
- 3 Germany 446 works
- 4 Japan 309 works
- 5 France 249 works
- 6 India 234 works
- 7 Italy 222 works
- 8 Russia 220 works
- 9 United Kingdom 191 works
- 10 Canada 160 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Radiopharmaceutical Chemistry and Applications research?
By volume in 2022–2025, Memorial Sloan Kettering Cancer Center publishes the most Radiopharmaceutical Chemistry and Applications research, followed by The University of Texas MD Anderson Cancer Center and Cornell University.
By volume, 2022–2025
- 1 Memorial Sloan Kettering Cancer CenterUnited States 39 works
- 2 The University of Texas MD Anderson Cancer CenterUnited States 35 works
- 3 Cornell UniversityUnited States 26 works
- 4 University of Wisconsin–MadisonUnited States 25 works
- 5 Johns Hopkins UniversityUnited States 22 works
- 6 University of California, San FranciscoUnited States 22 works
- 7 Homi Bhabha National InstituteIndia 20 works
- 8 University of North Carolina at Chapel HillUnited States 19 works
- 9 Egyptian Atomic Energy AuthorityEgypt 19 works
- 10 Bhabha Atomic Research CentreIndia 19 works
Who are the leading researchers in Radiopharmaceutical Chemistry and Applications?
The most-cited researchers publishing on Radiopharmaceutical Chemistry and Applications include G. N. Taylor and Judith A. K. Howard.
- 1 G. N. Taylor Australia 7.7k citations
- 2 Judith A. K. Howard United Kingdom 5.5k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Radiopharmaceutical Chemistry and Applications research done?
The largest centres of Radiopharmaceutical Chemistry and Applications research in 2022–2025 are Beijing (China), Moscow (Russia), Shanghai (China) and New York (United States). Among places with at least 20 works in it, it is an unusually large share of all research in Luzhou.
Largest cities, 2022–2025
Where it is the local speciality
- LuzhouCN · 21.0 works15×
Location quotient: how much more of its research is in Radiopharmaceutical Chemistry and Applications than the world average.
Where is the best place to study Radiopharmaceutical Chemistry and Applications?
Among universities, judged by research, Saarland University, University of California, San Francisco and Cornell University score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | Saarland UniversityGermany | 54.2 | 29.9% | 8.6× | 11 | +57.4% |
| 2 | University of California, San FranciscoUnited States | 52.7 | 21.7% | 6.0× | 22 | +93.3% |
| 3 | Cornell UniversityUnited States | 50.4 | 24.3% | 4.5× | 26 | +53.1% |
| 4 | University of Alabama at BirminghamUnited States | 49.3 | 21.5% | 5.9× | 16 | +140.7% |
| 5 | The University of MelbourneAustralia | 48.8 | 45.8% | 2.3× | 12 | +12.6% |
| 6 | Homi Bhabha National InstituteIndia | 48.6 | 8.5% | 16.3× | 20 | — |
| 7 | University of British ColumbiaCanada | 48.4 | 31.3% | 3.0× | 17 | +61.5% |
| 8 | Technical University of MunichGermany | 46.1 | 34.6% | 2.8× | 13 | +59.7% |
| 9 | Heidelberg UniversityGermany | 44.8 | 26.3% | 4.5× | 14 | +25.4% |
| 10 | University of Wisconsin–MadisonUnited States | 44.3 | 19.7% | 4.6× | 25 | +29.4% |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is Radiopharmaceutical Chemistry and Applications research growing?
Output in 2018–2022 was 11% higher than in 2013–2017, peaking in 2025. The fastest-growing topics are Radiopharmaceutical Chemistry and Applications.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.